RYR1 and catecholaminergic polymorphic ventricular tachycardia: To shed light on the disease-causing mechanism of the three CPVT mutations that show effects on pharyngeal pump ability in C. elegans, we decided to use a 1,4-benzothiazepine known to enhance calstabin binding and to reduce leakiness of RyR.